<html>
<head>PUBMED IDs for HCC8</head>
<body bgcolor='#C5F0F2'><h1>HCC8</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15665299/'>Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer.</a> January 25  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17533369/'>Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha.</a> May 30  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19233551/'>Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells.</a> May 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19398556/'>Distinct biological roles for the notch ligands Jagged-1 and Jagged-2.</a> August 7  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19570984/'>Cell proliferation and epidermal growth factor signaling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1.</a> November 7  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19804422/'>Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification.</a> March 31  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20097731/'>Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells.</a> April 17  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20716641/'>TAK-701, a humanized monoclonal antibody to hepatocyte growth factor, reverses gefitinib resistance induced by tumor-derived HGF in non-small cell lung cancer with an EGFR mutation.</a> March 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20878103/'>Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS.</a> February 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22076923/'>PEBP4 gene expression and its significance in invasion and metastasis of non-small cell lung cancer.</a> February 7  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22091388/'>Signatures of drug sensitivity in nonsmall cell lung cancer.</a> November 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22133747/'>Conversion from the &quot;oncogene addiction&quot; to &quot;drug addiction&quot; by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation.</a> September 7  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22502680/'>MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.</a> August 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22502669/'>Paris polyphylla Smith extract induces apoptosis and activates cancer suppressor gene connexin26 expression.</a> August 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22634180/'>Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.</a> October 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22681918/'>[Effect and mechanism of gefitinib inhibition on non-small cell lung cancer radiosensitivity of HCC827 and H358 cell lines].</a> July 31  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22844075/'>Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.</a> July 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22863020/'>Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors.</a> March 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22983920/'>PEBP4 enhanced HCC827 cell proliferation and invasion ability and inhibited apoptosis.</a> March 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23026510/'>Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations.</a> August 31  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23026509/'>Vitamin D status and the Cdx-2 polymorphism of the vitamin D receptor gene are determining factors of bone mineral density in young healthy postmenopausal women.</a> August 31  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23045273/'>Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations.</a> November 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23065281/'>Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma.</a> June 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23073851/'>The expression and function of microRNA-203 in lung cancer.</a> March 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23266614/'>Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents.</a> August 28  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23319394/'>The novel phosphoinositide 3-kinase-mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factor.</a> July 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23395887/'>Downregulation of HER3 by a novel antisense oligonucleotide, EZN-3920, improves the antitumor activity of EGFR and HER2 tyrosine kinase inhibitors in animal models.</a> October 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23555954/'>miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.</a> September 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23555953/'>Melanopsin gene polymorphism I394T is associated with pupillary light responses in a dose-dependent manner.</a> September 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23555950/'>An efficient low cost method for gene transfer to T lymphocytes.</a> October 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23586056/'>Ubiquitin ligase Cbl-b is involved in icotinib (BPI-2009H)-induced apoptosis and G1 phase arrest of EGFR mutation-positive non-small-cell lung cancer.</a> November 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23588221/'>Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.</a> December 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23592446/'>mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy.</a> September 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23592442/'>[Trying to unravel an unresolved issue in regenerative medicine: gene expression profiling of MSCs].</a> April 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23681800/'>Numblike regulates proliferation, apoptosis, and invasion of lung cancer cell.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23690929/'>mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGF.</a> January 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23857284/'>Expression and significance of miRNA-21 and BTG2 in lung cancer.</a> February 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23894143/'>Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer.</a> May 20  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23938604/'>Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24068620/'>Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation.</a> July 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24167634/'>Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.</a> May 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24192512/'>Loss of an EGFR-amplified chromosome 7 as a novel mechanism of acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC cells.</a> October 2  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24192446/'>Genetic mapping of high caries experience on human chromosome 13.</a> January 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24192424/'>Genetic variations of ND5 gene of mtDNA in populations of Anopheles sinensis (Diptera: Culicidae) malaria vector in China.</a> August 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24192396/'>Screening of Y chromosome microdeletions in 46,XY partial gonadal dysgenesis and in patients with a 45,X/46,XY karyotype or its variants.</a> April 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24339922/'>Role of IGF-binding protein 3 in the resistance of EGFR mutant lung cancer cells to EGFR-tyrosine kinase inhibitors.</a> March 3  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24403856/'>Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domain.</a> September 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24489728/'>Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.</a> December 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24531534/'>Cytotoxicity of cyclometalated platinum complexes based on tridentate NCN and CNN-coordinating ligands: remarkable coordination dependence.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24983493/'>MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25117641/'>Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification.</a> December 18  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25117632/'>The CELSR1 polymorphisms rs6007897 and rs4044210 are associated with ischaemic stroke in Chinese Han population.</a> August 25  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25117629/'>Solubility assessment and on-line exposure confirmation in a patch-clamp assay for hERG (human ether-a-go-go-related gene) potassium channel inhibition.</a> June 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25193862/'>Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition.</a> August 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25370413/'>In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell lines.</a> July 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25613063/'>ARNT2 is downregulated and serves as a potential tumor suppressor gene in non-small cell lung cancer.</a> June 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25634113/'>AURKA upregulation plays a role in fibroblast-reduced gefitinib sensitivity in the NSCLC cell line HCC827.</a> January 31  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25740245/'>Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy.</a> February 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25780909/'>AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cells.</a> February 26  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26098000/'>MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition.</a> November 18  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26203858/'>Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.</a> April 14  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26370161/'>Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification.</a> June 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26370156/'>RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.</a> September 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26471306/'>LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation.</a> March 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26490646/'>Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer.</a> March 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26542886/'>Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells.</a> August 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26542862/'>Defect type, localization and marker gene expression determines early adverse events of matrix-associated autologous chondrocyte implantation.</a> September 30  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26575584/'>Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer.</a> November 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26575538/'>Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.</a> July 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26845230/'>Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer.</a> August 26  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26883272/'>Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.</a> June 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26950548/'>Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines.</a> July 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26996130/'>Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.</a> September 23  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27108960/'>Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray.</a> March 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27118644/'>[LRRC3B is Downregulated in Non-small Cell Lung Cancer and Connected with Cell Proliferation and Invasion].</a> March 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27176594/'>Overexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition.</a> March 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27176569/'>Long noncoding RNA ANRIL: a potential novel prognostic marker in cancer: a meta-analysis.</a> August 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27392970/'>Regulation of Collagen V Expression and Epithelial-Mesenchymal Transition by miR-185 and miR-186 during Idiopathic Pulmonary Fibrosis.</a> May 17  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27392968/'>Prevalence of hypervirulent Klebsiella pneumoniae-associated genes rmpA and magA in two tertiary hospitals in Houston, TX, USA.</a> February 9  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27409162/'>YAP promotes erlotinib resistance in human non-small cell lung cancer cells.</a> July 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27409149/'>MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease.</a> July 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27498924/'>MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer.</a> April 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27748834/'>MEK inhibitors against MET-amplified non-small cell lung cancer.</a> October 18  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27936391/'>Contrary influence of clinically applied sorafenib concentrations among hepatocellular carcinoma patients.</a> December 10  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27936341/'>Single nucleotide polymorphism of adiponectin +276 G/T is associated with the susceptibility to essential hypertension in a Turkish population.</a> December 10  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28115165/'>Repression of Smad3 by Stat3 and c-Ski/SnoN induces gefitinib resistance in lung adenocarcinoma.</a> January 25  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28345454/'>Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.</a> April 8  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28443459/'>Astragaloside IV sensitizes non-small cell lung cancer cells to gefitinib potentially via regulation of SIRT6.</a> June 14  2017<br></body></html>
